10 medicines held by Pierre Fabre Medicament on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Braftovi 50 mg Hard capsule EU/1/18/1314/001 |
ENCORAFENIB | Pierre Fabre Medicament | — |
| Braftovi 75 mg Hard capsule EU/1/18/1314/002 |
ENCORAFENIB | Pierre Fabre Medicament | — |
| Ebvallo 2.8 × 10^7 – 7.3 × 10^7 cells/mL dispersion for injection EU/1/22/1700/001 |
Tabelecleucel | Pierre Fabre Medicament | — |
| Javlor 25 mg/mL concentrate for solution for infusion EU/1/09/550/1-12 |
Vinflunine ditartrate | Pierre Fabre Medicament | — |
| Mektovi 15 mg Film-coated tablet EU/1/18/1315/001 |
BINMETINIB | Pierre Fabre Medicament | — |
| Mektovi 45 mg Film-coated tablet EU/1/18/1315/003-004 |
Binimetinib | Pierre Fabre Medicament | — |
| NAVELBINE 20 mg soft capsule PA0329/011/001 |
Vinorelbine | Pierre Fabre Medicament | Marketed |
| NAVELBINE 30 mg soft capsule PA0329/011/002 |
Vinorelbine | Pierre Fabre Medicament | Marketed |
| Nerlynx 40 mg Film-coated tablet EU/1/18/1311/001 |
Neratinib | Pierre Fabre Medicament | — |
| Obgemsa 75 mg film-coated tablets EU/1/24/1822/001-006 |
Vibegron | Pierre Fabre Medicament | — |
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.